Human Genome Epidemiology Literature Finder
|
Records 1 - 10 (of 10 Records) |
| Query Trace: Neoplasms and SLC31A1[original query] |
|---|
| Genetic polymorphism of SLC31A1 is associated with clinical outcomes of platinum-based chemotherapy in non-small-cell lung cancer patients through modulating microRNA-mediated regulation. Oncotarget 2018 May 9 (35): 23860-23877. Sun Chang, Zhang Zhuojun, Qie Jingbo, Wang Yi, Qian Ji, Wang Jiucun, Wu Junjie, Li Qiang, Bai Chunxue, Han Baohui, Gao Zhiqiang, Xu Jibin, Lu Daru, Jin Li, Wang Haiji |
| Is a pharmacogenomic panel useful to estimate the risk of oxaliplatin-related neurotoxicity in colorectal cancer patients? The pharmacogenomics journal 2019 Feb . Nichetti Federico, Falvella Felicia Stefania, Miceli Rosalba, Cheli Stefania, Gaetano Raffaella, Fucà Giovanni, Infante Gabriele, Martinetti Antonia, Antoniotti Carlotta, Falcone Alfredo, Di Bartolomeo Maria, Cremolini Chiara, de Braud Filippo, Pietrantonio Filip |
| Association between ABCC2 polymorphism and hematological toxicity in patients with esophageal cancer receiving platinum plus 5-fluorouracil therapy. Esophagus : official journal of the Japan Esophageal Society 2021 Aug . Fujita Kazuma, Motoyama Satoru, Sato Yusuke, Wakita Akiyuki, Nagaki Yushi, Minamiya Yoshihiro, Miura Masato |
| A pharmacogenetics study of platinum-based chemotherapy in lung cancer: ABCG2 polymorphism and its genetic interaction with SLC31A1 are associated with response and survival. Journal of Cancer 2021 2 12 (5): 1270-1283. Wang Liyan, Sun Chang, Li Xiangnan, Mao Chenxue, Qian Ji, Wang Jiucun, Wu Junjie, Li Qiang, Bai Chunxue, Han Baohui, Gao Zhiqiang, Xu Jibin, Yin Jiye, Liu Zhaoqian, Lu Daru, Jin Li, Wang Haiji |
| Cuproptosis-Related Gene - SLC31A1, FDX1 and ATP7B - Polymorphisms are Associated with Risk of Lung Cancer. Pharmacogenomics and personalized medicine 2022 15 733-742. Yun Yuhui, Wang Yun, Yang Ende, Jing X |
| A novel cuproptosis-related gene signature of prognosis and immune microenvironment in head and neck squamous cell carcinoma cancer. Journal of cancer research and clinical oncology 2022 11 149 (1): 203-218. Jiang Xu, Ke Jing, Jia Lifeng, An Xiang, Ma Haiyu, Li Zhongwan, Yuan W |
| Systematic pan-cancer analysis identifies SLC31A1 as a biomarker in multiple tumor types. BMC medical genomics 2023 3 16 (1): 61. Kong Fan-Sheng, Ren Chun-Yan, Jia Ruofan, Zhou Yuan, Chen Jian-Huan, Ma Yapi |
| Elucidating cuproptosis-related gene SLC31A1 diagnostic and prognostic values in cancer. American journal of translational research 2023 11 15 (10): 6026-6041. Jiaoping Mi, Juncong Luo, Huanwen Zeng, Hongyu Zhang, Muhammad Jamil, Mostafa A Abdel-Maksoud, Adel M Zakri, Akram A Alfuraydi, Ning Zhang, Mei Xi |
| The cuproptosis-related signature predicts the prognosis and immune microenvironments of primary diffuse gliomas: a comprehensive analysis. Human genomics 2024 7 18 (1): 74. Tao Chang, Yihan Wu, Xiaodong Niu, Zhiwei Guo, Jiahao Gan, Xiang Wang, Yanhui Liu, Qi Pan, Qing Mao, Yuan Ya |
| Novel cuprotosis-related gene signature: a prognostic indicator and regulator of the glioma immune microenvironment. Translational cancer research 2024 12 13 (11): 6282-6297. Dongming Gao, Lin Zhou, Youyuan Bao, Wenyin Shi, Lei Li, Liang G |
- Page last reviewed:Feb 1, 2024
- Content source: